Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
113.27
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
38
39
Next >
5 Top Stocks to Buy With Your End-of-the-Year Bonus
December 23, 2023
Your bonus could become the gift that keeps on giving.
Via
The Motley Fool
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?
Via
The Motley Fool
Dividend Income Update For November 2023
December 16, 2023
It’s dividend income update time. This is one of my favorite times of the month, as I get to review the previous month of passive income received from my dividend income portfolio.
Via
Talk Markets
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
These players have what it takes to boost your portfolio over time.
Via
The Motley Fool
Where Abbott Laboratories Stands With Analysts
December 13, 2023
Via
Benzinga
AbbVie continues shopping spree with biotech buyout
December 12, 2023
While the diversifying AbbVie appears to be in a state of flux, there is one constant investors can depend on — the dividend.
Via
MarketBeat
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
December 05, 2023
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
December 01, 2023
Via
Benzinga
2 Healthcare Stocks to Buy Hand Over Fist in December
December 08, 2023
These stocks are great options now -- and most any month.
Via
The Motley Fool
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.
December 07, 2023
These particular players look cheap right now.
Via
The Motley Fool
Spotlight on Abbott Laboratories: Analyzing the Surge in Options Activity
November 30, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
November 30, 2023
Via
Benzinga
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
November 30, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc.
Via
Benzinga
Medtronic: oversold, overextended high yield reversal in play
November 22, 2023
The reversal in Medtronic has been brewing for some time but is gaining traction after strong second quarter earnings that came with improved guidance
Via
MarketBeat
Exposures
COVID-19
1 Stock Down 15% This Year to Buy and Hold Forever
November 02, 2023
This stock has been delivering solid performances for a long time.
Via
The Motley Fool
2 No-Brainer Dividend Stocks to Buy This Week
October 30, 2023
These two top-income stocks are too cheap to ignore.
Via
The Motley Fool
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
November 21, 2023
Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.
Via
Benzinga
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
November 20, 2023
New medicines for weight loss and diabetes stand to disrupt the competitive scene.
Via
The Motley Fool
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
November 17, 2023
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing
November 14, 2023
You'll be happy to own these top companies in any market environment.
Via
The Motley Fool
Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore'
November 13, 2023
Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes.
Via
Investor's Business Daily
2 No-Brainer Stocks to Buy for Forever Dividend Growth
November 09, 2023
These companies generate billions of dollars in free cash flow every year.
Via
The Motley Fool
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
November 08, 2023
Investors could be making a mistake by selling off these stocks this year.
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via
Benzinga
3 Dividend Kings to Buy for Royal Returns
November 06, 2023
Unlock the secrets of dividend kings, the aristocrats of the stock market with unparalleled records of raising dividends yearly.
Via
InvestorPlace
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever
November 04, 2023
Dividend stocks can cushion your portfolio in times of market trouble.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 02, 2023
Via
Benzinga
3 Dividend Stocks That Are Investor Safe Havens
November 02, 2023
If there is such a thing as safe dividend stocks, these three should be at the top of your list to consider.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 31, 2023
Via
Benzinga
SLB, Abbott And 2 Other Stocks Insiders Are Selling
October 31, 2023
The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.